Maintenance of Human T Cell Anergy: Blocking of IL-2 Gene Transcription by Activated Rap1
Vassiliki A. Boussiotis(Beth Israel Deaconess Medical Center), Lee M. Nadler(Dana-Farber Cancer Institute), Dwayne L. Barber(University of Toronto), Alla Berezovskaya(Ontario Institute for Cancer Research), Gordon J. Freeman(Dana-Farber Cancer Institute)
Cited by 412
Related Papers
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
|Nature Immunology|2001|3k
Reactivity of a monoclonal antibody with human ovarian carcinoma.
|Journal of Clinical Investigation|1981|1.7k
Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway
|New England Journal of Medicine|2016|1.4k
PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation
|Nature Communications|2015|1.2k